Supplementary Table S8 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Supplementary Table S8 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

<p>Supplementary Table S8. Quantification of each protein-specific band normalized to vinculin (Dox-inducible RM-1-BM– and C4-2b–derived models, Fig. 3A, 3B).</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Chuandong Geng (17315310) (author)
Diğer Yazarlar:	Man-Chao Zhang (17315313) (author), Ganiraju C. Manyam (17315316) (author), Jody V. Vykoukal (17315319) (author), Johannes F. Fahrmann (15052230) (author), Shan Peng (17315322) (author), Cheng Wu (17315325) (author), Sanghee Park (17315328) (author), Shakuntala Kondraganti (17315331) (author), Daoqi Wang (17315334) (author), Brian D. Robinson (16755326) (author), Massimo Loda (14958363) (author), Christopher E. Barbieri (15012150) (author), Timothy A. Yap (15028749) (author), Paul G. Corn (17315337) (author), Samir Hanash (17314360) (author), Bradley M. Broom (15022580) (author), Patrick G. Pilié (15119957) (author), Timothy C. Thompson (17315340) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling DNA Damage and Repair Drug Mechanisms Genitourinary Cancers Prostate cancer Small Molecule Agents
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Figure S8 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S10 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S12 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S14 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S15 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S16 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S17 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S18 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S19 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S20 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S21 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S5 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S6 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S7 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S10 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S12 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S5 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S6 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S7 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
Yazar:: Chuandong Geng (17315310)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data S8 from Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Yazar:: Naoual Menssouri (16617248)
Baskı/Yayın Bilgisi: (2025)

Image 8_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff
Yazar:: Elisabeth Damisch (22679276)
Baskı/Yayın Bilgisi: (2025)

<b>Patient and Physician Perspectives on Prostate Cancer Data Presented at ASCO 2025: A Podcast</b>
Yazar:: Adis Journals on behalf of: (10953492)
Baskı/Yayın Bilgisi: (2025)

FigureS8 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
Yazar:: Jonathan Chou (14957015)
Baskı/Yayın Bilgisi: (2025)

Figure 1 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Yazar:: Martin Sjöström (14845882)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Yazar:: Martin Sjöström (14845882)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Yazar:: Martin Sjöström (14845882)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_jpuep8vlsq42a8pq6em5rf9gp8